We showed, in this study, that SNRPD1 over-expression was prognostic of poor breast cancer survival, promoted cancer cell proliferation and migration due to, possibly, reduced cell cycle S phase and enhanced genome stability. Here, SNRPD1 is linked to breast cancer.